$BCAX News out
$BCAX Bicara Therapeutics Demonstrates Deep and Durable Responses with Ficerafusp Alfa Plus Pembrolizumab in 1L HPV-Negative R/M HNSCC at ASCO 2025https://marketwirenews.com/news-releases/bicara-therapeutics-demonstrates-deep-and-durable-re-7249711831713343.html